Spain, France, Germany, and Italy reimburse darvadstrocel for perianal fistulae under national healthcare systems. Spain and Portugal additionally offer systemic MSC remission protocols with published outcome data. South Korea provides high-volume, cost-effective IBD cell therapy with rapid access. Belgium and the Netherlands operate specialised IBD cell therapy centres with robust follow-up. For EU fistula indication with reimbursement eligibility, French and German gastroenterology centres facilitate fastest pathway; for systemic remission, Spanish centres combine published evidence with reasonable cost.
Darvadstrocel for perianal fistulae costs approximately €7,000–9,500 per application in European centres. Systemic MSC induction therapy for active Crohn's or ulcerative colitis costs €6,000–8,000 per infusion protocol. Multiple fistulae or combined induction+maintenance regimens escalate costs to €12,000–20,000+ per year. Insurance coverage varies significantly: EU approved indication (perianal fistulae) is reimbursed by several national healthcare systems (Spain, France, Germany) with prior authorisation; systemic IBD remission therapy is rarely covered, classified as investigational. Out-of-pocket payment is standard for non-fistula indications.
Sunt un candidat? → · Crohn's & IBD: full overview → · Cost Boala Crohn și IBD → · Cost →
Revizuit medical de echipa editorială a StemCellAtlas cu Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) ale clinicii partenere Stem Plus (Sofia), în funcție de orientările ISSCR, FDA și EMA. Educational information, not medical advice; figures indicative.
Medicină regenerativă certificată GMP în inima UE — de la 3.000–8.000 €, o fracțiune din prețurile din SUA sau Germania. Protocoale personalizate pentru pacienți din peste 50 de țări.
Evaluare medicală gratuită